A similar phenotype was observed in cancer cells that share a sensitivity to the ACLY inhibitor HC, and we propose that citrate drives basal MICA expression by providing acetyl-CoA for histone acetylation that can modify chromatin structure around the MICA transcription start site. The gene discussed is ACLY; the disease is cancer.